Using telehealth to deliver palliative care to cancer patients November 17, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Pembrolizumab approved for triple-negative breast cancerNovember 16, 2020Breast CancerMetastatic Breast Cancer
New cancer drugs may have saved more than 1.2 million AmericansNovember 12, 2020Patient & Survivor CareBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
‘Test all patients with cancer’: One in eight have inherited mutationsNovember 12, 2020Patient & Survivor CareBreast CancerGynecologic CancerGenitourinary CancerGastrointestinal CancerLung Cancer
One-month delay in cancer treatment linked to increase in mortalityNovember 6, 2020Patient & Survivor CareBreast CancerCOVID-19 UpdatesHead & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastrointestinal Cancer
SRS instead of WBRT for patients with multiple brain metastasesOctober 29, 2020CNS/Brain CancerBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerPatient & Survivor Care
Cancer therapy affects sexual health in most patientsOctober 29, 2020Patient & Survivor CareBreast CancerGenitourinary CancerGynecologic Cancer
‘Tour de force’ study reveals therapeutic targets in 38% of cancer patientsOctober 27, 2020Patient & Survivor CareBreast CancerGenitourinary CancerGynecologic CancerLung CancerGastrointestinal Cancer
Lower BP and better tumor control with drug combo?October 26, 2020ImmunotherapyLung CancerBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastroenterology
Are oncologists ready to confront a second wave of COVID-19?October 21, 2020Practice ManagementBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
Combined features of benign breast disease tied to breast cancer riskOctober 19, 2020Breast CancerPreventive Care